Ex vivo blockade of endothelin-1 inhibits graft coronary artery disease in a rodent cardiac allograft model
- 1 April 2002
- journal article
- research article
- Published by Elsevier in The Journal of Heart and Lung Transplantation
- Vol. 21 (4), 417-424
- https://doi.org/10.1016/s1053-2498(01)00397-7
Abstract
No abstract availableThis publication has 26 references indexed in Scilit:
- Ex vivo gene therapy prevents chronic graft vascular disease in cardiac allograftsThe Journal of Thoracic and Cardiovascular Surgery, 1998
- Inhibition of vascular contraction by intracisternal administration of preproendothelin-1 mRNA antisense oligoDNA in a rat experimental vasospasm modelJournal of Neurosurgery, 1996
- INCREASED ENDOTHELIN EXPRESSION IN A RAT CARDIAC ALLOGRAFT MODEL OF CHRONIC VASCULAR REJECTION1Transplantation, 1996
- Gene therapy for donor hearts: Ex vivo liposome-mediated transfectionThe Journal of Thoracic and Cardiovascular Surgery, 1996
- ENDOTHELIN-1 IMMUNOREACTIVITY AND mRNA IN THE TRANSPLANTED HUMAN HEARTTransplantation, 1995
- Immunopathology of cardiac transplant rejectionCurrent Opinion in Cardiology, 1995
- MULTIPLE VECTORS EFFECTIVELY ACHIEVE GENE TRANSFER IN A MURINE CARDIAC TRANSPLANTATION MODEL IMMUNOSUPPRESSION WITH TGF-β OR vIL-10Transplantation, 1995
- Regulation of human aortic endothelial cell-derived mesenchymal growth factors by allogeneic lymphocytes in vitro. A potential mechanism for cardiac allograft vasculopathy.JCI Insight, 1993
- Effects of successful cardiac transplantation on plasma endothelinThe American Journal of Cardiology, 1993
- cDNA cloning, sequence analysis and tissue distribution of rat preproendothelin-1 mRNABiochemical and Biophysical Research Communications, 1991